Study of the Genetic Factors Involved in Autism and Related Disorders

Recruiting Observational Study
Autism Spectrum Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
24 Months – 70
Sex
Any
Study type
Observational
Participants needed
3,800 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The main objective of the study is to define, for Autism Spectrum Disorder, the extent of genetic variation in synaptic pathways that may be targeted for therapeutic development. For this purpose the investigators will take advantage of large, well-characterized cohorts of patients with Autism Spectrum Disorder for genetic screenings. Targeted sequencing of selected synaptic genes, previously asso…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria--------------------------------------------------------------------------------------------------- Probands with Autism Spectrum Disorder * Meet the diagnostic criteria for ASD of the DSM-5 \[American Psychiatric Association, 2013\] based on a consensus between the clinical expe…
Contacts

Richard Delorme, M.D, Ph.D

+33662725334

richard.delorme@aphp.fr

CONTACT

Marion Leboyer, M.D, Ph.D

+33149813131

marion.leboyer@inserm.fr

CONTACT